nodes	percent_of_prediction	percent_of_DWPC	metapath
Rimantadine—Gastrointestinal symptom NOS—Salbutamol—chronic obstructive pulmonary disease	0.0168	0.0168	CcSEcCtD
Rimantadine—Rigors—Salbutamol—chronic obstructive pulmonary disease	0.0121	0.0121	CcSEcCtD
Rimantadine—Pallor—Salbutamol—chronic obstructive pulmonary disease	0.0119	0.0119	CcSEcCtD
Rimantadine—Disturbance in attention—Montelukast—chronic obstructive pulmonary disease	0.0118	0.0118	CcSEcCtD
Rimantadine—Depression—Roflumilast—chronic obstructive pulmonary disease	0.0115	0.0115	CcSEcCtD
Rimantadine—Atrioventricular block—Arformoterol—chronic obstructive pulmonary disease	0.0108	0.0108	CcSEcCtD
Rimantadine—Atrioventricular block—Formoterol—chronic obstructive pulmonary disease	0.0108	0.0108	CcSEcCtD
Rimantadine—Hyperkinesia—Montelukast—chronic obstructive pulmonary disease	0.00892	0.00892	CcSEcCtD
Rimantadine—Tension—Roflumilast—chronic obstructive pulmonary disease	0.00883	0.00883	CcSEcCtD
Rimantadine—Nervousness—Roflumilast—chronic obstructive pulmonary disease	0.00874	0.00874	CcSEcCtD
Rimantadine—Hyperkinesia—Salbutamol—chronic obstructive pulmonary disease	0.0086	0.0086	CcSEcCtD
Rimantadine—Mental disability—Salbutamol—chronic obstructive pulmonary disease	0.00856	0.00856	CcSEcCtD
Rimantadine—Euphoric mood—Salbutamol—chronic obstructive pulmonary disease	0.00848	0.00848	CcSEcCtD
Rimantadine—Tremor—Roflumilast—chronic obstructive pulmonary disease	0.00843	0.00843	CcSEcCtD
Rimantadine—Dysphagia—Tiotropium—chronic obstructive pulmonary disease	0.00812	0.00812	CcSEcCtD
Rimantadine—Palpitations—Roflumilast—chronic obstructive pulmonary disease	0.00795	0.00795	CcSEcCtD
Rimantadine—Anxiety—Roflumilast—chronic obstructive pulmonary disease	0.00763	0.00763	CcSEcCtD
Rimantadine—Stomatitis—Tiotropium—chronic obstructive pulmonary disease	0.00706	0.00706	CcSEcCtD
Rimantadine—Ataxia—Salbutamol—chronic obstructive pulmonary disease	0.00673	0.00673	CcSEcCtD
Rimantadine—Insomnia—Roflumilast—chronic obstructive pulmonary disease	0.00664	0.00664	CcSEcCtD
Rimantadine—Dyspepsia—Roflumilast—chronic obstructive pulmonary disease	0.00646	0.00646	CcSEcCtD
Rimantadine—Bronchospasm—Formoterol—chronic obstructive pulmonary disease	0.00645	0.00645	CcSEcCtD
Rimantadine—Bronchospasm—Arformoterol—chronic obstructive pulmonary disease	0.00645	0.00645	CcSEcCtD
Rimantadine—Oedema peripheral—Tiotropium—chronic obstructive pulmonary disease	0.0064	0.0064	CcSEcCtD
Rimantadine—Decreased appetite—Roflumilast—chronic obstructive pulmonary disease	0.00638	0.00638	CcSEcCtD
Rimantadine—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.00634	0.00634	CcSEcCtD
Rimantadine—Fatigue—Roflumilast—chronic obstructive pulmonary disease	0.00633	0.00633	CcSEcCtD
Rimantadine—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.00628	0.00628	CcSEcCtD
Rimantadine—Bronchospasm—Salbutamol—chronic obstructive pulmonary disease	0.00609	0.00609	CcSEcCtD
Rimantadine—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.00605	0.00605	CcSEcCtD
Rimantadine—Sweating increased—Salbutamol—chronic obstructive pulmonary disease	0.00603	0.00603	CcSEcCtD
Rimantadine—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.00601	0.00601	CcSEcCtD
Rimantadine—Tension—Aminophylline—chronic obstructive pulmonary disease	0.00589	0.00589	CcSEcCtD
Rimantadine—Nervousness—Aminophylline—chronic obstructive pulmonary disease	0.00583	0.00583	CcSEcCtD
Rimantadine—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.00581	0.00581	CcSEcCtD
Rimantadine—Tremor—Aminophylline—chronic obstructive pulmonary disease	0.00562	0.00562	CcSEcCtD
Rimantadine—Agitation—Aminophylline—chronic obstructive pulmonary disease	0.00551	0.00551	CcSEcCtD
Rimantadine—Stomatitis—Salbutamol—chronic obstructive pulmonary disease	0.00538	0.00538	CcSEcCtD
Rimantadine—Palpitations—Aminophylline—chronic obstructive pulmonary disease	0.0053	0.0053	CcSEcCtD
Rimantadine—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.00527	0.00527	CcSEcCtD
Rimantadine—Convulsion—Aminophylline—chronic obstructive pulmonary disease	0.0052	0.0052	CcSEcCtD
Rimantadine—Oedema peripheral—Arformoterol—chronic obstructive pulmonary disease	0.00517	0.00517	CcSEcCtD
Rimantadine—Oedema peripheral—Formoterol—chronic obstructive pulmonary disease	0.00517	0.00517	CcSEcCtD
Rimantadine—Hallucination—Montelukast—chronic obstructive pulmonary disease	0.00511	0.00511	CcSEcCtD
Rimantadine—Hypoaesthesia—Montelukast—chronic obstructive pulmonary disease	0.00511	0.00511	CcSEcCtD
Rimantadine—Anxiety—Aminophylline—chronic obstructive pulmonary disease	0.00509	0.00509	CcSEcCtD
Rimantadine—Syncope—Tiotropium—chronic obstructive pulmonary disease	0.00508	0.00508	CcSEcCtD
Rimantadine—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.00503	0.00503	CcSEcCtD
Rimantadine—Palpitations—Tiotropium—chronic obstructive pulmonary disease	0.005	0.005	CcSEcCtD
Rimantadine—Loss of consciousness—Tiotropium—chronic obstructive pulmonary disease	0.00497	0.00497	CcSEcCtD
Rimantadine—Cough—Tiotropium—chronic obstructive pulmonary disease	0.00494	0.00494	CcSEcCtD
Rimantadine—Hypoaesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00493	0.00493	CcSEcCtD
Rimantadine—Hypertension—Tiotropium—chronic obstructive pulmonary disease	0.00489	0.00489	CcSEcCtD
Rimantadine—Euphoric mood—Prednisolone—chronic obstructive pulmonary disease	0.00486	0.00486	CcSEcCtD
Rimantadine—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00486	0.00486	CcSEcCtD
Rimantadine—Shock—Aminophylline—chronic obstructive pulmonary disease	0.00482	0.00482	CcSEcCtD
Rimantadine—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.00478	0.00478	CcSEcCtD
Rimantadine—Dry mouth—Tiotropium—chronic obstructive pulmonary disease	0.00471	0.00471	CcSEcCtD
Rimantadine—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00467	0.00467	CcSEcCtD
Rimantadine—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.00467	0.00467	CcSEcCtD
Rimantadine—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00463	0.00463	CcSEcCtD
Rimantadine—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00463	0.00463	CcSEcCtD
Rimantadine—Tinnitus—Salbutamol—chronic obstructive pulmonary disease	0.00462	0.00462	CcSEcCtD
Rimantadine—Headache—Roflumilast—chronic obstructive pulmonary disease	0.0046	0.0046	CcSEcCtD
Rimantadine—Shock—Tiotropium—chronic obstructive pulmonary disease	0.00454	0.00454	CcSEcCtD
Rimantadine—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.00451	0.00451	CcSEcCtD
Rimantadine—Tension—Formoterol—chronic obstructive pulmonary disease	0.00448	0.00448	CcSEcCtD
Rimantadine—Tension—Arformoterol—chronic obstructive pulmonary disease	0.00448	0.00448	CcSEcCtD
Rimantadine—Chills—Salbutamol—chronic obstructive pulmonary disease	0.00445	0.00445	CcSEcCtD
Rimantadine—Nervousness—Arformoterol—chronic obstructive pulmonary disease	0.00444	0.00444	CcSEcCtD
Rimantadine—Nervousness—Formoterol—chronic obstructive pulmonary disease	0.00444	0.00444	CcSEcCtD
Rimantadine—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.00443	0.00443	CcSEcCtD
Rimantadine—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00436	0.00436	CcSEcCtD
Rimantadine—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.00431	0.00431	CcSEcCtD
Rimantadine—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.00428	0.00428	CcSEcCtD
Rimantadine—Tremor—Formoterol—chronic obstructive pulmonary disease	0.00428	0.00428	CcSEcCtD
Rimantadine—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.00426	0.00426	CcSEcCtD
Rimantadine—Tension—Salbutamol—chronic obstructive pulmonary disease	0.00423	0.00423	CcSEcCtD
Rimantadine—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.0042	0.0042	CcSEcCtD
Rimantadine—Agitation—Formoterol—chronic obstructive pulmonary disease	0.0042	0.0042	CcSEcCtD
Rimantadine—Tremor—Montelukast—chronic obstructive pulmonary disease	0.00419	0.00419	CcSEcCtD
Rimantadine—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.00419	0.00419	CcSEcCtD
Rimantadine—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.00418	0.00418	CcSEcCtD
Rimantadine—Agitation—Montelukast—chronic obstructive pulmonary disease	0.00411	0.00411	CcSEcCtD
Rimantadine—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.00407	0.00407	CcSEcCtD
Rimantadine—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.00404	0.00404	CcSEcCtD
Rimantadine—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.00404	0.00404	CcSEcCtD
Rimantadine—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.00404	0.00404	CcSEcCtD
Rimantadine—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.004	0.004	CcSEcCtD
Rimantadine—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.00399	0.00399	CcSEcCtD
Rimantadine—Cough—Arformoterol—chronic obstructive pulmonary disease	0.00399	0.00399	CcSEcCtD
Rimantadine—Cough—Formoterol—chronic obstructive pulmonary disease	0.00399	0.00399	CcSEcCtD
Rimantadine—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.00396	0.00396	CcSEcCtD
Rimantadine—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.00395	0.00395	CcSEcCtD
Rimantadine—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.00395	0.00395	CcSEcCtD
Rimantadine—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.00394	0.00394	CcSEcCtD
Rimantadine—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.00394	0.00394	CcSEcCtD
Rimantadine—Cough—Montelukast—chronic obstructive pulmonary disease	0.0039	0.0039	CcSEcCtD
Rimantadine—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.00388	0.00388	CcSEcCtD
Rimantadine—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.00387	0.00387	CcSEcCtD
Rimantadine—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.00387	0.00387	CcSEcCtD
Rimantadine—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.00387	0.00387	CcSEcCtD
Rimantadine—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.00387	0.00387	CcSEcCtD
Rimantadine—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.00381	0.00381	CcSEcCtD
Rimantadine—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.0038	0.0038	CcSEcCtD
Rimantadine—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.0038	0.0038	CcSEcCtD
Rimantadine—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.0038	0.0038	CcSEcCtD
Rimantadine—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.00379	0.00379	CcSEcCtD
Rimantadine—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.00378	0.00378	CcSEcCtD
Rimantadine—Cough—Salbutamol—chronic obstructive pulmonary disease	0.00376	0.00376	CcSEcCtD
Rimantadine—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.00372	0.00372	CcSEcCtD
Rimantadine—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.00366	0.00366	CcSEcCtD
Rimantadine—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.00365	0.00365	CcSEcCtD
Rimantadine—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.00364	0.00364	CcSEcCtD
Rimantadine—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.00364	0.00364	CcSEcCtD
Rimantadine—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.00359	0.00359	CcSEcCtD
Rimantadine—Hyperkinesia—Prednisone—chronic obstructive pulmonary disease	0.00359	0.00359	CcSEcCtD
Rimantadine—Euphoric mood—Prednisone—chronic obstructive pulmonary disease	0.00353	0.00353	CcSEcCtD
Rimantadine—Shock—Salbutamol—chronic obstructive pulmonary disease	0.00346	0.00346	CcSEcCtD
Rimantadine—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.00346	0.00346	CcSEcCtD
Rimantadine—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.00344	0.00344	CcSEcCtD
Rimantadine—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.0034	0.0034	CcSEcCtD
Rimantadine—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.00337	0.00337	CcSEcCtD
Rimantadine—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.00337	0.00337	CcSEcCtD
Rimantadine—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.00335	0.00335	CcSEcCtD
Rimantadine—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00335	0.00335	CcSEcCtD
Rimantadine—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.00332	0.00332	CcSEcCtD
Rimantadine—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.00332	0.00332	CcSEcCtD
Rimantadine—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.00331	0.00331	CcSEcCtD
Rimantadine—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.00331	0.00331	CcSEcCtD
Rimantadine—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.0033	0.0033	CcSEcCtD
Rimantadine—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.00328	0.00328	CcSEcCtD
Rimantadine—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.00328	0.00328	CcSEcCtD
Rimantadine—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.00325	0.00325	CcSEcCtD
Rimantadine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00324	0.00324	CcSEcCtD
Rimantadine—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00322	0.00322	CcSEcCtD
Rimantadine—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00322	0.00322	CcSEcCtD
Rimantadine—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.00321	0.00321	CcSEcCtD
Rimantadine—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.00321	0.00321	CcSEcCtD
Rimantadine—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.00321	0.00321	CcSEcCtD
Rimantadine—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.00319	0.00319	CcSEcCtD
Rimantadine—Constipation—Formoterol—chronic obstructive pulmonary disease	0.00319	0.00319	CcSEcCtD
Rimantadine—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.00318	0.00318	CcSEcCtD
Rimantadine—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00315	0.00315	CcSEcCtD
Rimantadine—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.00315	0.00315	CcSEcCtD
Rimantadine—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.00314	0.00314	CcSEcCtD
Rimantadine—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.00313	0.00313	CcSEcCtD
Rimantadine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00311	0.00311	CcSEcCtD
Rimantadine—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.0031	0.0031	CcSEcCtD
Rimantadine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00309	0.00309	CcSEcCtD
Rimantadine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00309	0.00309	CcSEcCtD
Rimantadine—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.00307	0.00307	CcSEcCtD
Rimantadine—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.00307	0.00307	CcSEcCtD
Rimantadine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00307	0.00307	CcSEcCtD
Rimantadine—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.00306	0.00306	CcSEcCtD
Rimantadine—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.00306	0.00306	CcSEcCtD
Rimantadine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00305	0.00305	CcSEcCtD
Rimantadine—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.00305	0.00305	CcSEcCtD
Rimantadine—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.00305	0.00305	CcSEcCtD
Rimantadine—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00304	0.00304	CcSEcCtD
Rimantadine—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.00303	0.00303	CcSEcCtD
Rimantadine—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.00301	0.00301	CcSEcCtD
Rimantadine—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.00299	0.00299	CcSEcCtD
Rimantadine—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.00295	0.00295	CcSEcCtD
Rimantadine—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.00295	0.00295	CcSEcCtD
Rimantadine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00294	0.00294	CcSEcCtD
Rimantadine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00291	0.00291	CcSEcCtD
Rimantadine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00291	0.00291	CcSEcCtD
Rimantadine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00291	0.00291	CcSEcCtD
Rimantadine—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.0029	0.0029	CcSEcCtD
Rimantadine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00289	0.00289	CcSEcCtD
Rimantadine—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.00289	0.00289	CcSEcCtD
Rimantadine—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.00288	0.00288	CcSEcCtD
Rimantadine—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.00278	0.00278	CcSEcCtD
Rimantadine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00274	0.00274	CcSEcCtD
Rimantadine—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.00267	0.00267	CcSEcCtD
Rimantadine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.00267	0.00267	CcSEcCtD
Rimantadine—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.00262	0.00262	CcSEcCtD
Rimantadine—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.00255	0.00255	CcSEcCtD
Rimantadine—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.00255	0.00255	CcSEcCtD
Rimantadine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.00253	0.00253	CcSEcCtD
Rimantadine—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.00251	0.00251	CcSEcCtD
Rimantadine—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.0025	0.0025	CcSEcCtD
Rimantadine—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00246	0.00246	CcSEcCtD
Rimantadine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00246	0.00246	CcSEcCtD
Rimantadine—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00241	0.00241	CcSEcCtD
Rimantadine—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.00241	0.00241	CcSEcCtD
Rimantadine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.00237	0.00237	CcSEcCtD
Rimantadine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.00237	0.00237	CcSEcCtD
Rimantadine—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00235	0.00235	CcSEcCtD
Rimantadine—Rash—Formoterol—chronic obstructive pulmonary disease	0.00235	0.00235	CcSEcCtD
Rimantadine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.00235	0.00235	CcSEcCtD
Rimantadine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.00235	0.00235	CcSEcCtD
Rimantadine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00234	0.00234	CcSEcCtD
Rimantadine—Headache—Formoterol—chronic obstructive pulmonary disease	0.00234	0.00234	CcSEcCtD
Rimantadine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.00233	0.00233	CcSEcCtD
Rimantadine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.00232	0.00232	CcSEcCtD
Rimantadine—Rash—Montelukast—chronic obstructive pulmonary disease	0.0023	0.0023	CcSEcCtD
Rimantadine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.0023	0.0023	CcSEcCtD
Rimantadine—Depression—Prednisone—chronic obstructive pulmonary disease	0.00229	0.00229	CcSEcCtD
Rimantadine—Headache—Montelukast—chronic obstructive pulmonary disease	0.00229	0.00229	CcSEcCtD
Rimantadine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.00224	0.00224	CcSEcCtD
Rimantadine—Rash—Salbutamol—chronic obstructive pulmonary disease	0.00222	0.00222	CcSEcCtD
Rimantadine—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.00222	0.00222	CcSEcCtD
Rimantadine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.00222	0.00222	CcSEcCtD
Rimantadine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00221	0.00221	CcSEcCtD
Rimantadine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00221	0.00221	CcSEcCtD
Rimantadine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.0022	0.0022	CcSEcCtD
Rimantadine—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.00217	0.00217	CcSEcCtD
Rimantadine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00217	0.00217	CcSEcCtD
Rimantadine—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.00214	0.00214	CcSEcCtD
Rimantadine—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.00214	0.00214	CcSEcCtD
Rimantadine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00209	0.00209	CcSEcCtD
Rimantadine—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.00205	0.00205	CcSEcCtD
Rimantadine—Shock—Prednisolone—chronic obstructive pulmonary disease	0.00199	0.00199	CcSEcCtD
Rimantadine—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.00197	0.00197	CcSEcCtD
Rimantadine—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.00195	0.00195	CcSEcCtD
Rimantadine—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.00183	0.00183	CcSEcCtD
Rimantadine—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.00166	0.00166	CcSEcCtD
Rimantadine—Agitation—Prednisone—chronic obstructive pulmonary disease	0.00165	0.00165	CcSEcCtD
Rimantadine—Syncope—Prednisone—chronic obstructive pulmonary disease	0.00161	0.00161	CcSEcCtD
Rimantadine—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.00158	0.00158	CcSEcCtD
Rimantadine—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.00156	0.00156	CcSEcCtD
Rimantadine—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.00155	0.00155	CcSEcCtD
Rimantadine—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.00152	0.00152	CcSEcCtD
Rimantadine—Shock—Prednisone—chronic obstructive pulmonary disease	0.00144	0.00144	CcSEcCtD
Rimantadine—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.00143	0.00143	CcSEcCtD
Rimantadine—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.00142	0.00142	CcSEcCtD
Rimantadine—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.0014	0.0014	CcSEcCtD
Rimantadine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.00133	0.00133	CcSEcCtD
Rimantadine—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.00133	0.00133	CcSEcCtD
Rimantadine—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.00129	0.00129	CcSEcCtD
Rimantadine—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.00128	0.00128	CcSEcCtD
Rimantadine—Rash—Prednisolone—chronic obstructive pulmonary disease	0.00127	0.00127	CcSEcCtD
Rimantadine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.00127	0.00127	CcSEcCtD
Rimantadine—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.00126	0.00126	CcSEcCtD
Rimantadine—Headache—Prednisolone—chronic obstructive pulmonary disease	0.00126	0.00126	CcSEcCtD
Rimantadine—Constipation—Prednisone—chronic obstructive pulmonary disease	0.00125	0.00125	CcSEcCtD
Rimantadine—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.00121	0.00121	CcSEcCtD
Rimantadine—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.0012	0.0012	CcSEcCtD
Rimantadine—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.0012	0.0012	CcSEcCtD
Rimantadine—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.00116	0.00116	CcSEcCtD
Rimantadine—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.00105	0.00105	CcSEcCtD
Rimantadine—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.001	0.001	CcSEcCtD
Rimantadine—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.00097	0.00097	CcSEcCtD
Rimantadine—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000933	0.000933	CcSEcCtD
Rimantadine—Rash—Prednisone—chronic obstructive pulmonary disease	0.000925	0.000925	CcSEcCtD
Rimantadine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000924	0.000924	CcSEcCtD
Rimantadine—Headache—Prednisone—chronic obstructive pulmonary disease	0.000919	0.000919	CcSEcCtD
Rimantadine—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000871	0.000871	CcSEcCtD
